Clinical trial technology specialist Cytel has received the Society for Clinical annual Trial of the Year Award. The TOGETHER Trial for COVID-19 therapies, designed by Cytel, used statistical expertise to reach accelerated testing of 11 interventions, as well as deployment of study infrastructure designed to help low-income communities find cost-effective therapies
Cytel’s principal research scientist Edward Mills (professor of Health Research Methods at McMaster University in Canada, said, "In a rush to find therapies that work, members of the global community failed to recognize that much of the world would not be able to afford a number of the therapies initially put forward for examination. Members of the TOGETHER Trial joined to ensure that low- and middle-income countries did not miss out on the global search for effective results. I see the recognition from SCT as a recognition of global scientific cooperation."